15 results on '"Gerard Tiraby"'
Search Results
2. Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.
- Author
-
Nicolas Rochereau, Daniel Drocourt, Eric Perouzel, Vincent Pavot, Pierre Redelinghuys, Gordon D Brown, Gerard Tiraby, Xavier Roblin, Bernard Verrier, Christian Genin, Blaise Corthésy, and Stéphane Paul
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Intestinal microfold (M) cells possess a high transcytosis capacity and are able to transport a broad range of materials including particulate antigens, soluble macromolecules, and pathogens from the intestinal lumen to inductive sites of the mucosal immune system. M cells are also the primary pathway for delivery of secretory IgA (SIgA) to the gut-associated lymphoid tissue. However, although the consequences of SIgA uptake by M cells are now well known and described, the mechanisms whereby SIgA is selectively bound and taken up remain poorly understood. Here we first demonstrate that both the Cα1 region and glycosylation, more particularly sialic acid residues, are involved in M cell-mediated reverse transcytosis. Second, we found that SIgA is taken up by M cells via the Dectin-1 receptor, with the possible involvement of Siglec-5 acting as a co-receptor. Third, we establish that transcytosed SIgA is taken up by mucosal CX3CR1⁺ dendritic cells (DCs) via the DC-SIGN receptor. Fourth, we show that mucosal and systemic antibody responses against the HIV p24-SIgA complexes administered orally is strictly dependent on the expression of Dectin-1. Having deciphered the mechanisms leading to specific targeting of SIgA-based Ag complexes paves the way to the use of such a vehicle for mucosal vaccination against various infectious diseases.
- Published
- 2013
- Full Text
- View/download PDF
3. Cloning of an aminoglycoside-resistance-encoding gene, kamC, from Saccharopolyspora hirsuta: comparison with kamB from Streptomyces tenebrarius
- Author
-
David J. Holmes, Eric Cundliffe, Daniel Drocourt, and Gerard Tiraby
- Subjects
Transcription, Genetic ,Kanamycin Resistance ,Molecular Sequence Data ,Restriction Mapping ,RRNA methylation ,Molecular cloning ,Biology ,medicine.disease_cause ,Homology (biology) ,Bacterial Proteins ,RNA, Ribosomal, 16S ,Sequence Homology, Nucleic Acid ,Genetics ,medicine ,Escherichia coli ,Nebramycin ,Amino Acid Sequence ,Cloning, Molecular ,Saccharopolyspora hirsuta ,Gene ,Base Sequence ,Nucleic acid sequence ,Drug Resistance, Microbial ,General Medicine ,Methyltransferases ,biology.organism_classification ,Streptomyces ,Saccharopolyspora - Abstract
An aminoglycoside-resistance-encoding gene (kamC) has been isolated from the sporaricin producer, Saccharopolyspora (Sac.) hirsuta, and expressed both in Streptomyces lividans and Escherichia coli. The pattern of resistance conferred by this gene was identical to that given by another gene (kamB) previously isolated from Streptomyces tenebrarius. In accordance with the known action of the kamB product, the Sac. hirsuta determinant also encodes a methyltransferase that modifies 16S rRNA, thereby rendering ribosomes refractory to certain aminoglycosides. The nucleotide sequences of both genes have been determined and comparison of the deduced amino acid sequences reveals a high degree of similarity.
- Published
- 1991
4. A novel gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth
- Author
-
Fabienne, Vernejoul, primary, Anny, Souque, additional, Laurent, Ghenassia, additional, Gerard, Tiraby, additional, Lucien, Pradayrol, additional, and Louis, Buscail, additional
- Published
- 2003
- Full Text
- View/download PDF
5. Crystallographic studies of the mechanism of xylose isomerase
- Author
-
Gregory K. Farber, Gregory A. Petsko, Dagmar Ringe, Gerard Tiraby, and Arthur Glasfeld
- Subjects
Xylose isomerase ,Aldose-Ketose Isomerases ,Protein Conformation ,Stereochemistry ,Molecular Sequence Data ,Isomerase ,Biochemistry ,Triosephosphate isomerase ,Isomerism ,Sequence Homology, Nucleic Acid ,Escherichia coli ,Magnesium ,Amino Acid Sequence ,chemistry.chemical_classification ,Manganese ,Binding Sites ,Crystallography ,Molecular Structure ,biology ,Chemistry ,Hydride ,Substrate (chemistry) ,Active site ,Streptomyces ,Glucose ,Enzyme ,biology.protein ,Carbohydrate Epimerases ,Bacillus subtilis - Abstract
The mechanism of xylose isomerase (EC 5.3.1.5) has been studied with X-ray crystallography. Four refined crystal structures are reported at 3-A resolution: native enzyme, enzyme + glucose, enzyme + glucose + Mg2+, and enzyme + glucose + Mn2+. One of these structures (E.G.Mg) was determined in a crystal mounted in a flow cell. The other structures were equilibrium experiments carried out by soaking crystals in substrate containing solution. These structures and other studies suggest that, contrary to expectation, xylose isomerase may not use the generally expected base-catalyzed enolization mechanism. A mechanism involving a hydride shift is consistent with the structures presented here and warrants further investigation. Additional evidence in support of a hydride shift comes from comparing xylose isomerase with triosephosphate isomerase which is known to catalyze an analogous reaction via an enediol intermediate. Evidence is presented that suggests that aldose-ketose isomerases can be divided into two groups. Phospho sugar isomerases generally do not require a metal ion for activity and show exchange of substrate protons with solvent. In contrast, simple sugar isomerases all require a metal ion and show very low solvent exchange. These observations are rationalized on the basis of the need for stereospecific sugar binding.
- Published
- 1989
6. RECOGNITION OF STREPTOCOCCAL DNA BY A MUTANT PNEUMOCOCCUS UNABLE TO DISCRIMINATE AMONG MARKERS IN PNEUMOCOCCAL DNA
- Author
-
Gerard Tiraby and Arnold W. Ravin
- Subjects
DNA, Bacterial ,Mutant ,Erythromycin ,Microbial Sensitivity Tests ,Investigations ,Biology ,medicine.disease_cause ,Microbiology ,chemistry.chemical_compound ,Transformation, Genetic ,Species Specificity ,Mutant strain ,Streptococcus pneumoniae ,Genetics ,medicine ,Mutation ,Streptococcus ,Lincomycin ,Transformation (genetics) ,chemistry ,Streptomycin ,Rifampin ,Fusidic Acid ,DNA ,medicine.drug - Abstract
A mutant strain of pneumococcus which fails to discriminate against low-efficiency markers during transformation by homospecific pneumococcal donor DNA retains the wild-type capacity to discriminate against heterospecific (streptococcal) donor DNA. We conclude that discrimination against heterospecific DNA must differ from that against low-efficiency markers by the kind or number of elements being recognized.
- Published
- 1973
7. INTEGRATION EFFICIENCY IN DNA-INDUCED TRANSFORMATION OF PNEUMOCOCCUS. I. A METHOD OF TRANSFORMATION IN SOLID MEDIUM AND ITS USE FOR ISOLATION OF TRANSFORMATION-DEFICIENT AND RECOMBINATION-MODIFIED MUTANTS
- Author
-
Jean-Pierre Claverys, Gerard Tiraby, and Michel Sicard
- Subjects
DNA, Bacterial ,Time Factors ,Ultraviolet Rays ,Mutant ,Drug Resistance ,Investigations ,Biology ,Tritium ,medicine.disease_cause ,chemistry.chemical_compound ,Transformation, Genetic ,Methods ,Genetics ,Ultraviolet light ,medicine ,Cinchona ,Nitrosoguanidines ,Recombination, Genetic ,Bacteriological Techniques ,Mutation ,Plants, Medicinal ,Replica plating ,Biological Transport ,Aminopterin ,Erythromycin ,Radiation Effects ,Transformation (genetics) ,Streptococcus pneumoniae ,chemistry ,Streptomycin ,DNA ,Recombination ,Thymidine ,Transformation efficiency - Abstract
A method of transformation on solid medium especially adapted for pneumococcus has been developed. Under specific conditions, all colonies that are allowed to grow in the presence of transforming DNA for six hours give rise to transformed bacteria. Combined with replica plating this technique has been used to isolate mutants modified with regard to recombination. Most of the mutants found are transformation-defective and show a large diversity in their response to ultraviolet light. Some of these mutants have lost their ability to take up transforming DNA. One shows a reduced yield of transformants for a given quantity of DNA taken up. Mutants that manifest altered behavior with regard to marker efficiencies have also been isolated. One of these exhibits a decrease in the transformation efficiency of only the high efficiency markers and two mutants show a decrease in the transformation efficiency of the low efficiency markers.
- Published
- 1973
8. Chloramphenicol resistance in Streptococcus pneumoniae: enzymatic acetylation and possible plasmid linkage
- Author
-
William V. Shaw, Jacques F. Acar, Annie Dang-Van, Gerard Tiraby, and Daniel H. Bouanchaud
- Subjects
Biosynthesis ,Chemistry ,Mechanisms of Action and Resistance ,R Factors ,Mutagenesis (molecular biology technique) ,Biology ,medicine.disease_cause ,Microbiology ,Chloramphenicol acetyltransferase ,chemistry.chemical_compound ,Chloramphenicol Resistance ,Plasmid ,Streptococcus pneumoniae ,medicine ,Pharmacology (medical) ,Pharmacology ,Chloramphenicol ,Acetylation ,Transformation (genetics) ,Infectious Diseases ,chemistry ,Mutation ,Transformation, Bacterial ,DNA, Circular ,Ethidium bromide ,medicine.drug - Abstract
Clinical isolates of Streptococcus pneumoniae resistant to chloramphenicol were observed in France for the first time in 1973. During a 4-year survey, these strains were found to represent 6% of a total of 564 isolates of S. pneumoniae in a general hospital and to belong to 13 different serotypes. One such strain, referred to as BM 6001, was shown to inactivate chloramphenicol, and the process was found to be inducible. The inactivated products were demonstrated to be O -acetoxy esters of chloramphenicol. The synthesis of an inducible chloramphenicol acetyltransferase was shown to be responsible for the inactivation of the drug. The resistant strain was able to transfer the chloramphenicol marker by transformation to competent strains of pneumococci at a frequency of 1% of that observed for control chromosomal markers. The loss of resistance was enhanced by ethidium bromide treatment, but no chloramphenicol-resistant mutant was isolated by mutagenesis of a “cured” clone or naturally susceptible isolates. All attempts to isolate plasmid deoxyribonucleic acid as covalently closed circular molecules from strain BM 6001 have been unsuccessful, but epidemiological evidence and the fact that the genes specifying chloramphenicol acetyltransferase synthesis are usually located on plasmids suggest that this marker may be plasmid-borne in S. pneumoniae .
- Published
- 1978
9. Crystallography and Site-Directed Mutagenesis of Two Isomerases
- Author
-
Thomas C. Alber, Robert C. Davenport, Gregory K. Farber, D. Ann Giammona, Arthur M. Glasfeld, William D. Horrocks, Masaharu Kanaoka, Elias Lolis, Gregory A. Petsko, Dagmar Ringe, and Gerard Tiraby
- Published
- 1989
10. Integration efficiencies of spontaneous mutant alleles of amiA locus in pneumococcal transformation
- Author
-
Gerard Tiraby and Michel Sicard
- Subjects
Genetics ,DNA, Bacterial ,Mutation rate ,Bacteriological Techniques ,Mutant ,Locus (genetics) ,Drug Resistance, Microbial ,Genetics and Molecular Biology ,Biology ,Microbiology ,Aminopterin ,Streptococcus pneumoniae ,Transformation, Genetic ,Genetic marker ,Mutation ,Allele ,Molecular Biology ,Alleles - Abstract
The distribution of integration efficiencies of independent mutations spontaneously occurring in the amiA locus was determined in two strains of pneumococcus. Strain Cl 3 integrates genetic markers with different efficiencies during transformation, whereas strain 401, isogenic with strain Cl 3 , does not discriminate between markers and integrates all markers with the same high efficiency. The discriminating strain Cl 3 gives rise to spontaneous mutations in the locus amiA , which fall into four classes with respect to their individual integration efficiencies. Mutations with a low efficiency of integration are equal in number to mutations with a high efficiency. Mutations from the two other classes corresponding to intermediate and very high efficiencies are about five times less frequent. The same four classes were also found among amiA mutants spontaneously occurring in strain 401. However, the two distributions of integration efficiencies of amiA mutants arisen either in strain Cl 3 or strain 401 are significantly different. The number of spontaneous amiA mutants, estimated by two methods, was found to be higher in strain 401 than in strain Cl 3 . The increase of the mutation rate in strain 401 could be accounted for by the excess of mutations falling in the two less-efficient classes observed in this strain. The discriminating process which acts during transformation presumably also intervenes in the appearance of spontaneous mutations.
- Published
- 1973
11. Integration Efficiency in DNA-Induced Transformation of PNEUMOCOCCUS. II. Genetic Studies of Mutant Integrating All the Markers with a High Efficiency
- Author
-
Michel Sicard and Gerard Tiraby
- Subjects
DNA, Bacterial ,Time Factors ,Ultraviolet Rays ,Mutant ,Drug Resistance ,Biology ,Investigations ,chemistry.chemical_compound ,Transformation, Genetic ,Species Specificity ,Genetics ,Ultraviolet light ,Radiation Genetics ,Cinchona ,Ultraviolet radiation ,Nitrosoguanidines ,Recombination, Genetic ,Plants, Medicinal ,Strain (chemistry) ,Biological Transport ,Dose-Response Relationship, Radiation ,Molecular biology ,Aminopterin ,Erythromycin ,Transformation (genetics) ,Kinetics ,Phenotype ,Streptococcus pneumoniae ,chemistry ,Mutation ,Streptomycin ,Photon beams ,Recombination ,DNA - Abstract
Transformation of the pneumococcus mutant 401 by DNA's bearing the standard reference marker and several other markers belonging to two unlinked loci has shown that differences in the integration efficiencies of these markers were considerably reduced in this strain compared to the wild-type strain Cl 3. The sensitivities of mutant 401 to ultraviolet light and to X-ray irradiation are the same as those of Cl 3. However, in 401 all the markers tested are more resistant to inactivation as shown by transformation of 401 and Cl 3 by ultraviolet-irradiated DNA. The increase in resistance is greater for low efficiency (LE) markers than for high efficiency (HE) markers.—The decreased discrimination between LE and HE markers in strain 401 is not due to a mechanism related to modification of markers in the transforming DNA by the recipient cells, nor are the proteins inducing competence of the cells responsible for the differences in the integration efficiencies of various markers.—Genetic studies of the fate of recombinants as well as the measure of the amount of DNA taken up have shown that all the markers are integrated in strain 401 by the same recombination process, that specific to high efficiency markers.
- Published
- 1973
12. Inhibition of phage infection by pneumococcus capsule
- Author
-
Harriet P. Bernheimer and Jean-Gerard Tiraby
- Subjects
chemistry.chemical_classification ,Lysis ,viruses ,Polysaccharides, Bacterial ,Wild type ,Capsule ,Biology ,Virus Replication ,Virology ,Microbiology ,Streptococcus pneumoniae ,Enzyme ,chemistry ,Cell Wall ,Mutation ,Bacteriophages ,Lysogeny - Abstract
Fifty-two strains of pneumococci were tested for sensitivity to lysis by pneumococcus phages ω2, ω3, and ω8. Nine noncapsulated strains derived from seven different wildtype strains were all lysed by the three phages. Two strains carrying the Cs capsule were as sensitive as their parent noncapsulated strains. Forty-one other capsulated strains were insensitive to lysis by any of the phages. Although capsulation apparently severely limits adsorption of phage, capsulated cells can release phage; infection by ω3 of a type 3 pneumococcus temporarily denuded of its capsule by enzymatic action resulted in a burst of progeny phage at a time when the host cell had regained full capsulation.
- Published
- 1976
13. Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells
- Author
-
Virginie Pascal, Brice Laffleur, Arnaud Debin, Armelle Cuvillier, Marjolein van Egmond, Daniel Drocourt, Laurent Imbertie, Céline Pangault, Karin Tarte, Gérard Tiraby, and Michel Cogné
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Background While most antibody-based therapies use IgG because of their well-known biological properties, some functional limitations of these antibodies call for the development of derivatives with other therapeutic functions. Although less abundant than IgG in serum, IgA is the most abundantly produced Ig class in humans. Besides the specific targeting of its dimeric form to mucosal areas, IgA was shown to recruit polymorphonuclear neutrophils against certain targets more efficiently than does IgG1.Design and Methods In this study, we investigated the various pathways by which anti-tumor effects can be mediated by anti-CD20 IgA against lymphoma cells.Results We found that polymeric human IgA was significantly more effective than human IgG1 in mediating direct killing or growth inhibition of target cells in the absence of complement. We also demonstrated that this direct killing was able to indirectly induce the classical pathway of the complement cascade although to a lesser extent than direct recruitment of complement by IgG. Recruitment of the alternative complement pathway by specific IgA was also observed. In addition to activating complement for lysis of lymphoma cell lines or primary cells from patients with lymphoma, we showed that monomeric anti-CD20 IgA can effectively protect mice against tumor development in a passive immunization strategy and we demonstrated that this protective effect may be enhanced in mice expressing the human FcαRI receptor on their neutrophils.Conclusions We show that anti-CD20 IgA antibodies have original therapeutic properties against lymphoma cells, with strong direct effects, ability to recruit neutrophils for cell cytotoxicity and even recruitment of complement, although largely through an indirect way.
- Published
- 2012
- Full Text
- View/download PDF
14. Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities.
- Author
-
Marlène Cot, Aurélie Ray, Martine Gilleron, Alain Vercellone, Gérald Larrouy-Maumus, Elise Armau, Sophie Gauthier, Gérard Tiraby, Germain Puzo, and Jérôme Nigou
- Subjects
Medicine ,Science - Abstract
Gram positive bacteria produce cell envelope macroamphiphile glycopolymers, i.e. lipoteichoic acids or lipoglycans, whose functions and biosynthesis are not yet fully understood. We report for the first time a detailed structure of lipoteichoic acid isolated from a Streptomyces species, i.e. Streptomyces hygroscopicus subsp. hygroscopicus NRRL 2387T. Chemical, MS and NMR analyses revealed a polyglycerolphosphate backbone substituted with α-glucosaminyl and α-N-acetyl-glucosaminyl residues but devoid of any amino-acid substituent. This structure is very close, if not identical, to that of the wall teichoic acid of this organism. These data not only contribute to the growing recognition that lipoteichoic acid is a cell envelope component of gram positive Actinobacteria but also strongly support the recently proposed hypothesis of an overlap between the pathways of lipoteichoic acid and wall teichoic acid synthesis in these bacteria. S. hygroscopicus lipoteichoic acid induced signalling by human innate immune receptor TLR2, confirming its role as a microbe-associated molecular pattern. Its activity was partially dependant on TLR1, TLR6 and CD14. Moreover, it stimulated TNF-α and IL-6 production by a human macrophage cell line to an extent similar to that of Staphylococcus aureus lipoteichoic acid. These results provide new clues on lipoteichoic acid structure/function relationships, most particularly on the role of the polyglycerolphosphate backbone substituents.
- Published
- 2011
- Full Text
- View/download PDF
15. Biocatalysis and Biomimetics
- Author
-
JAMES D. BURRINGTON, DOUGLAS S. CLARK, Mary L. Good, Paul B. Weisz, Judah Folkman, Thomas C. Alber, Robert C. Davenport, Gregory K. Farber, D. Ann Giammona, Arthur M. Glasfeld, William D. Horrocks, Masaharu Kanaoka, Elias Lolis, Gregory A. Petsko, Dagmar Ringe, Gerard Tiraby, Gilles Klopman, Ruben E. Venegas, Adel M. Naylor, William A. Goddard, J. W. Shield, H. D. Ferguson, K. K. Gleason, T. A. Hatton, Louise Creagh, Paul Skerker, Mark Guinn, John Prausnitz, Harvey Blanch, Richard H. Fish, Raymond H. Fong, Robert T. Price, John B. Vincent, George Christou, Robert DiCosimo, Hsiao-Chiung Szabo, Norman Herron, R. Sipehia, J. Daka, A. S. Chawla, T. M. S. Chang, JAMES D. BURRINGTON, DOUGLAS S. CLARK, Mary L. Good, Paul B. Weisz, Judah Folkman, Thomas C. Alber, Robert C. Davenport, Gregory K. Farber, D. Ann Giammona, Arthur M. Glasfeld, William D. Horrocks, Masaharu Kanaoka, Elias Lolis, Gregory A. Petsko, Dagmar Ringe, Gerard Tiraby, Gilles Klopman, Ruben E. Venegas, Adel M. Naylor, William A. Goddard, J. W. Shield, H. D. Ferguson, K. K. Gleason, T. A. Hatton, Louise Creagh, Paul Skerker, Mark Guinn, John Prausnitz, Harvey Blanch, Richard H. Fish, Raymond H. Fong, Robert T. Price, John B. Vincent, George Christou, Robert DiCosimo, Hsiao-Chiung Szabo, Norman Herron, R. Sipehia, J. Daka, A. S. Chawla, and T. M. S. Chang
- Subjects
- Enzymes--Biotechnology--Congresses, Biomimetics--Biotechnology--Congresses
- Published
- 1989
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.